Agile Therapeutics, Inc. (AGRX): $1.12

-0.04 (-3.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Agile Therapeutics Inc (AGRX) Price Targets From Analysts

Use the tables below to see what analysts covering Agile Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $7 $6 $6.25 $1.26 396.03%

The Trend in the Analyst Price Target


AGRX's average price target has moved down $0.95 over the prior 14 months.

AGRX reports an average of 258.39% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 4 7 6 6.25 1.14 448.25%
2021-07-10 4 7 6 6.25 1.28 388.28%
2021-07-03 4 7 6 6.25 1.35 362.96%
2021-06-15 4 7 6 6.25 1.52 311.18%
2021-06-13 4 7 6 6.25 1.54 305.84%
2021-06-05 4 7 6 6.25 1.53 308.5%
2021-05-22 4 7 6 6.25 1.71 265.5%
2021-05-15 4 7 6 6.25 1.61 288.2%
2021-04-22 4 10 7 8.25 1.83 350.82%
2021-04-17 4 10 7 8.25 1.82 353.3%
2021-03-23 4 10 7 8.25 1.88 338.83%
2021-03-20 4 10 7 8.25 2.07 298.55%
2021-03-13 4 10 7 8.25 2.20 275%
2021-03-06 4 10 7 8.25 2.23 269.96%
2021-01-29 4 10 7 8.25 2.82 192.55%
2021-01-23 4 10 7 8.25 2.94 180.61%
2021-01-16 4 10 7 8.25 2.81 193.59%
2021-01-09 4 10 7 8.25 2.86 188.46%
2021-01-02 4 10 7 8.25 2.87 187.46%
2020-12-26 4 10 5 7.50 2.91 157.73%
2020-12-19 4 10 5 7.50 2.90 158.62%
2020-11-26 4 12 6 8.50 2.78 205.76%
2020-10-26 5 12 5 7.80 2.87 171.78%
2020-09-21 5 12 5 7.80 3.41 128.74%
2020-09-08 4 12 6 8.50 3.01 182.39%
2020-08-14 3 12 6 8.67 2.84 205.28%
2020-07-20 5 8 6 7.20 NA NA%
2020-06-07 5 8 6 7.20 NA NA%

AGRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 2 3 0 0 0 5

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The upside potential (average analyst target price relative to current price) of AGRX is greater than 96.44% of all US stocks.
  • AGRX has a higher average analyst price target than 11.57% of all US stocks.
  • Agile Therapeutics Inc's number of analysts covering the stock is higher than 84.3% of stocks in the micro market cap category.
  • AGRX has a less variance in analysts' estimates than 79.03% of Pharmaceutical Products stocks.

Stocks similar to Agile Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ARAV, ELDN and CLRB.

What is the outlook for AGRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6679 seconds.